Markets:

Overview

News

Currencies

International

Treasuries

Tilray Brands, Inc. - Common Stock (NQ:TLRY)

4.380 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tilray Brands, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Manitoba Harvest Launches Superfood Smoothie Boosters, Exclusively at Sprouts Farmers Market Nationwide

April 28, 2026

Introducing New Functional Superfood Smoothie Booster Blends that Add a Nutrient-Rich Boost to Your Daily Smoothies

From Tilray Brands, Inc.

Via GlobeNewswire

Marijuana Rescheduling Has Arrived. Don't Make This Mistake ↗

April 27, 2026

The Trump administration recently rescheduled medical marijuana from a Schedule I to Schedule III substance.

Via The Motley Fool

Topics Cannabis Government

This Trump Policy Shift Could Be a Game Changer for Cannabis Stocks: 2 Stocks to Watch Now

April 27, 2026

A federal shift toward Schedule 3 may boost cannabis stocks, even as recreational use remains restricted.

Via Barchart.com

Topics Cannabis Government Law Enforcement

Is Tilray a Textbook Example of a Value Trap? ↗

April 25, 2026

Tilray doesn't fit squarely into the value trap or value stock categories.

Via The Motley Fool

Topics Cannabis

The Cannabis Sector's Billion-Dollar Tax Cut ↗

April 23, 2026

Via MarketBeat

Topics Cannabis

Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling

April 23, 2026

Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for Patients

From Tilray Brands, Inc.

Via GlobeNewswire

BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer

April 23, 2026

From Tilray Brands, Inc.

Via GlobeNewswire

420 with CNW — CNN Documentary Explores How Medical Marijuana is Helping Women

April 22, 2026

Via Investor Brand Network

Topics Cannabis

420 with CNW — CNN Documentary Explores How Medical Marijuana is Helping Women

April 22, 2026

Via CannabisNewsWire

Topics Cannabis

Tilray Stock Jumps As Trump Administration Eyes Marijuana Reclassification: Report ↗

April 22, 2026

Shares of Tilray Brands (NASDAQ: TLRY) are trading higher Wednesday afternoon following breaking news of a potential major regulatory shift.

Via Benzinga

Topics Cannabis Government

1 Wall Street Analyst Says Tilray Stock Could Jump Over 40%. Should You Believe It? ↗

April 22, 2026

Tilray is showing signs of improvement. But a 40% jump over the next 12 months might be a stretch.

Via The Motley Fool

Topics Cannabis

Here's What to Expect From Air Products and Chemicals' Next Earnings Report

April 20, 2026

Air Products and Chemicals is expected to release its fiscal second-quarter earnings this month, and analysts project a double-digit earnings growth.

Via Barchart.com

Topics Cannabis ETFs

Tilray Stock Pops on New Trump-Driven Cannabis Hopes. Should You Chase the Rally?

April 20, 2026

Tilray shares rally as Trump urges the DOJ to quickly reclassify cannabis as a Schedule III drug. Options pricing suggests TLRY stock could rip higher through mid-September.

Via Barchart.com

Topics Cannabis Government

Apple's Q2 2026 Earnings: What to Expect

April 20, 2026

Apple is expected to announce its second-quarter results this month, and analysts are projecting a double-digit rise in its EPS

Via Barchart.com

Topics Cannabis ETFs

The 420 Failure: Here's the Real Reason Tilray Brands Has Been a Horrible Investment Despite Operating in a Legal Marijuana Market ↗

April 20, 2026

The cannabis stock has lost around 96% of its value over the past five years.

Via The Motley Fool

Topics Cannabis

Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care

April 20, 2026

From Tilray Brands, Inc.

Via GlobeNewswire

Why Is Tilray Brands Stock Falling Wednesday? ↗

April 15, 2026

Tilray (TLRY) shares dip on a $180M equity program. Explore its global push into U.K. healthcare, BrewDog growth, and U.S. market strategy.

Via Benzinga

Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership

April 15, 2026

Tilray Advances UK Healthcare Platform with Lyphe Acquisition, Positions BrewDog for Strong Growth, and Prepares for U.S. Rescheduling and Medical Cannabis Opportunity

From Tilray Brands, Inc.

Via GlobeNewswire

Tilray Posted Record Numbers Last Quarter, but Where the Bulk of Its Growth Has Come From Over the Past 4 Years Might Surprise You ↗

April 13, 2026

Tilray has leaned on acquisitions heavily over the past few years in order to grow its business.

Via The Motley Fool

Topics Cannabis

420 with CNW — Advisory Council Recommends Marijuana Legalization in North Carolina

April 09, 2026

Via Investor Brand Network

Topics Cannabis

420 with CNW — Advisory Council Recommends Marijuana Legalization in North Carolina

April 09, 2026

Via CannabisNewsWire

Topics Cannabis

Why Tilray Stock Got Hammered in March ↗

April 08, 2026

What's another month of struggle for a company in the cannabis industry?

Via The Motley Fool

Topics Cannabis

What's Going On With Tilray Brands Stock On Wednesday? ↗

April 08, 2026

Tilray shares gained after launching a high-potency cannabis brand, with innovation and strong momentum outweighing mixed technical signals.

Via Benzinga

Topics Cannabis

Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey—A Must-Try for Whiskey Enthusiasts

April 07, 2026

First Released in 2025 as the limited-edition Broncos Whiskey, Breckenridge Honey Whiskey Delivers Distinctive Character and Exceptional Flavor

From Tilray Brands, Inc.

Via GlobeNewswire

Why Tilray Brands Investors Shouldn't Expect the Company to Post a Profit Anytime Soon ↗

April 06, 2026

The company's loss shrank drastically last quarter, but that was largely because it didn't incur significant impairment charges.

Via The Motley Fool

Topics Cannabis

Tilray Brands Reports Record Q3 2026 Results: A Deep Dive into the $207 Million Revenue Milestone

April 06, 2026

Tilray Brands (NASDAQ:TLRY) has officially transitioned from a volatile cannabis producer to a diversified global consumer packaged goods (CPG) powerhouse, reporting record-breaking Q3 fiscal 2026...

Via MarketMinute

Topics Cannabis Earnings Economy

Forget Tilray: This Boring Dividend Beast Is a Much Savvier Play ↗

April 04, 2026

And it's in a cannabis-adjacent sector.

Via The Motley Fool

Topics Cannabis

Tilray Brands Surges on Record $207 Million Q3 Revenue: Margin Recovery in Beverages and German Cannabis Growth Signal Turnaround

April 02, 2026

NEW YORK — Tilray Brands, Inc. (NASDAQ:TLRY) delivered a resounding message to the market this week, reporting a record-breaking $206.7 million in net revenue for its fiscal 2026 third quarter. The...

Via MarketMinute

Topics Cannabis Earnings Economy

Tilray Stock Continues To Climb After Earnings Beat, Record Revenue ↗

April 02, 2026

Tilray Brands shares are trading higher Thursday afternoon after the company's fiscal Q3 results topped Wall Street expectations.

Via Benzinga

Topics Earnings

Tilray Surges on Record Revenue and Global Expansion Despite Third-Quarter Earnings Miss

April 01, 2026

In a paradoxical display of market confidence, shares of Tilray Brands (NASDAQ:TLRY) surged over 8% on Wednesday following the release of its fiscal third-quarter 2026 financial results. While the...

Via MarketMinute

Topics Cannabis Earnings

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.